The CIN pathway in colon cancer is characterized by mutation in the APC oncosuppressor gene or deletion of chromosome 5q, containing APC, mutation of K-RAS, deletion of chromosome 18q and deletion of chromosome 17p, containing TP53. This evidence concerns the gene KRAS and malignant colon neoplasm.